Press Release Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies 1 hour ago
Press Release Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results Aug 13
Press Release Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma Aug 10